VTRS Live signaler | Maksimer profitt med Getagraph.com

SELG 17 min ago

@ $10.62

Utstedt: 1 jul 2024 @ 20:07

Avkastning: -0.05%

Forrige signal: jul 1 - 17:41

Forrige signal: Kjøp

Avkastning: 0.43 %

Live Chart Being Loaded With Signals

Commentary (1 jul 2024 @ 20:25):
Our systems believe the stock currently is overvalued by -0.03% compare to its pairs and should correct downwards.

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets...

Stats
Dagens volum	3.47M
Gjennomsnittsvolum	8.17M
Markedsverdi	12.63B
EPS	$0.0953 ( Q1 \| 2024-05-09 )
Neste inntjeningsdato	( $0.670 ) 2024-08-04
Last Dividend	$0.120 ( 2024-05-23 )
Next Dividend	$0 ( N/A )
P/E	-212.20 (Sector) 42.63 (Industry) 0
ATR14	$0.235 (2.21%)

ACOR -24.02%

ACRX 7.50%

ADMP 0.85%

ADMS 0.00%

AGRX 0.71%

AKAN -3.46%

ALIM -0.63%

AMPH -3.93%

AMYT 0.00%

ANIP -0.64%

AQST -6.53%

ASRT -0.40%

ATNX 0.00%

AVDL -1.00%

AYTU -4.45%

BFRI -2.00%

BGXX 6.67%

CLVR -1.89%

COLL 0.96%

CPIX -3.27%

CRDL -1.24%

CRON -1.50%

CYTH -5.40%

DCPH 0.00%

DERM -3.37%

DRRX 0.53%

DVAX -0.67%

EGRX -3.75%

EMBC -2.40%

EMBCV -9.33%

EOLS 1.57%

ESPR 6.08%

EVOK -4.54%

FLGC -3.19%

FLXN 0.00%

GHSI -1.68%

HCM 2.98%

HROW 1.24%

HUGE -8.49%

IMCC -4.13%

INCR 1.92%

IRWD 1.23%

ITCI -2.45%

IXHL 0.34%

JUPW 11.76%

KALA -1.64%

KIN 0.11%

KMDA -1.20%

LNTH -0.77%

NBIX 1.60%

NEPT 0.00%

NLTX 1.45%

OGI 0.33%

OPTN 2.42%

ORGO -1.43%

PAHC 2.09%

PCRX 0.56%

PETQ 1.52%

PLXP 0.00%

PPD 0.00%

PROC 3.48%

PRPH -3.47%

PTPI -3.49%

RDHL 0.49%

RDUS 0.92%

REPH -0.48%

RGC -5.03%

RMTI -2.27%

SCTL 0.92%

SCYX -4.50%

SIGA -0.92%

SISI -15.38%

SNDL 0.53%

SNOA 5.75%

SSIC -2.79%

SUPN -0.26%

SXTC 0.00%

THTX -1.41%

TKNO -10.22%

TLGT -13.85%

TLRY 1.20%

TXMD 5.90%

TYHT -3.90%

UPC 3.75%

VTRS -0.19%

ZYNE 2.36%

Insider Trading

Date	Person	Action	Amount	type
2024-06-13	Malik Rajiv	Sell	85 660	Common Stock
2024-06-14	Malik Rajiv	Sell	264 300	Common Stock
2024-06-03	Vivaldi Coelho Rogerio	Buy	21 267	Restricted Stock Units
2024-06-03	Vivaldi Coelho Rogerio	Buy	0
2024-05-28	Roman Brian	Sell	89 419	Common Stock

INSIDER POWER
-9.12
Last 98 transactions
Buy: 1 324 055 \| Sell: 1 537 802

Korrelasjon (AI algo v.1.1b): Overvalued: -0.03% $10.62 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: 0.80 (moderate)

Kort: 0.57 (weak)

Signal:(60) Neutral

Viatris Inc. Korrelasjon

10 Mest positive korrelasjoner
IGMS	0.804

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Viatris Inc. Korrelasjon - Valuta/Råvare

-0.63
( weak negative )

-0.66
( moderate negative )

0.00
( neutral )

0.53
( weak )

-0.21
( neutral )

Viatris Inc. Økonomi

Annual	2023
Omsetning:	$15.38B
Bruttogevinst:	$6.57B (42.70 %)
EPS:	$0.0456

FY	2023
Omsetning:	$15.38B
Bruttogevinst:	$6.57B (42.70 %)
EPS:	$0.0456

FY	2022
Omsetning:	$16.26B
Bruttogevinst:	$6.50B (39.95 %)
EPS:	$1.710

FY	2021
Omsetning:	$17.89B
Bruttogevinst:	$5.58B (31.17 %)
EPS:	$-2.11

Financial Reports:

No articles found.

Viatris Inc. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.120 (N/A)	$0.120 (N/A)	$0.120 (N/A)	$0.120 (N/A)	$0.240 (N/A)	$0.120 (N/A)	$0.120 (N/A)	$0.120 (N/A)	$0 (N/A)	$0 (N/A)

Viatris Inc. Dividend Information - Dividend Knight

Dividend Sustainability Score: 4.93 - low (63.78%) | Divividend Growth Potential Score: 0.668 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.00741	1986-12-24
Last Dividend	$0.120	2024-05-23
Next Dividend	$0	N/A
Payout Date	2024-06-14
Next Payout Date	N/A
# dividends	90	--
Total Paid Out	$3.23	--
Avg. Dividend % Per Year	3.02%	--
Score	4.45	--
Div. Sustainability Score	4.93
Div.Growth Potential Score	0.668
Div. Directional Score	2.80	--

Next Divdend (Est)
(2024-08-05)

$0.122 Estimate 68.50 %

Dividend Stability

0.91 Excellent

Dividend Score

4.45

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1986	$0.00741	0.42%
1987	$0.0148	0.88%
1988	$0.0111	0.86%
1989	$0.0148	1.13%
1990	$0.0222	0.63%
1991	$0.0296	1.01%
1992	$0.0326	0.53%
1993	$0.0416	0.46%
1994	$0.0564	0.78%
1995	$0.0652	0.85%
1996	$0.0712	0.70%
1997	$0.0712	0.97%
1998	$0.0712	0.80%
1999	$0.0712	0.53%
2000	$0.0712	0.66%
2001	$0.0712	0.65%
2002	$0.0756	0.47%
2003	$0.0966	0.61%
2004	$0.120	0.48%
2005	$0.210	1.20%
2006	$0.240	1.20%
2007	$0.120	0.60%
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0.330	1.78%
2022	$0.480	3.38%
2023	$0.600	5.27%
2024	$0.240	2.11%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
23 May 2024	$0.120	06 May 2024	24 May 2024	14 Jun 2024
08 Mar 2024	$0.120	26 Feb 2024	11 Mar 2024	18 Mar 2024
22 Nov 2023	$0.120	07 Nov 2023	24 Nov 2023	15 Dec 2023
24 Aug 2023	$0.120	07 Aug 2023	24 Aug 2023	15 Sep 2023
23 Aug 2023	$0.120	04 Aug 2023	24 Aug 2023	15 Sep 2023
23 May 2023	$0.120	05 May 2023	24 May 2023	16 Jun 2023
08 Mar 2023	$0.120	24 Feb 2023	09 Mar 2023	17 Mar 2023
22 Nov 2022	$0.120	07 Nov 2022	23 Nov 2022	16 Dec 2022
23 Aug 2022	$0.120	04 Aug 2022	24 Aug 2022	16 Sep 2022
23 May 2022	$0.120	05 May 2022	24 May 2022	16 Jun 2022
23 Feb 2022	$0.120	06 Jan 2022	24 Feb 2022	16 Mar 2022
22 Nov 2021	$0.110	08 Nov 2021	23 Nov 2021	16 Dec 2021
23 Aug 2021	$0.110	09 Aug 2021	24 Aug 2021	16 Sep 2021
21 May 2021	$0.110	10 May 2021	24 May 2021	16 Jun 2021
27 Jun 2007	$0.0600	18 Jun 2007	29 Jun 2007	16 Jul 2007
28 Mar 2007	$0.0600	15 Mar 2007	30 Mar 2007	16 Apr 2007
27 Dec 2006	$0.0600	19 Dec 2006	29 Dec 2006	16 Jan 2007
27 Sep 2006	$0.0600	19 Sep 2006	29 Sep 2006	16 Oct 2006
28 Jun 2006	$0.0600	16 Jun 2006	30 Jun 2006	14 Jul 2006
29 Mar 2006	$0.0600	21 Mar 2006	31 Mar 2006	17 Apr 2006

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Diamond	2024-09-16	Monthly	14	15.03%	9.60
DMLP	Dividend Diamond	2024-04-26	Quarterly	22	10.71%	9.35
OXSQ	Dividend Diamond	2024-09-16	Monthly	21	12.73%	9.02
ARLP	Dividend Royal	2024-05-07	Quarterly	26	9.67%	8.87
PNNT	Dividend Royal	2024-06-14	Monthly	18	9.49%	8.82
MFIC	Dividend Royal	2024-06-11	Quarterly	21	10.89%	8.79
SPOK	Dividend Royal	2024-05-23	Quarterly	20	8.73%	8.72
PSEC	Dividend Royal	2024-06-25	Monthly	21	9.03%	8.65
SBLK	Dividend Royal	2024-06-06	Quarterly	17	13.10%	8.63
GBDC	Dividend Royal	2024-11-29	Bi-Monthly	15	8.53%	8.62

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.00366	1.500	-0.0731	-0.110	[0 - 0.5]
returnOnAssetsTTM	-0.00118	1.200	-0.0395	-0.0474	[0 - 0.3]
returnOnEquityTTM	-0.00273	1.500	-1.141	-1.712	[0.1 - 1]
payoutRatioTTM	-10.24	-1.000	-10.00	10.00	[0 - 1]
currentRatioTTM	1.575	0.800	7.13	5.70	[1 - 3]
quickRatioTTM	0.651	0.800	-0.878	-0.703	[0.8 - 2.5]
cashRatioTTM	0.131	1.500	-0.384	-0.576	[0.2 - 2]
debtRatioTTM	0.382	-1.500	3.64	-5.46	[0 - 0.6]
interestCoverageTTM	3.08	1.000	9.97	9.97	[3 - 30]
operatingCashFlowPerShareTTM	2.04	2.00	9.32	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.674	2.00	9.16	10.00	[0 - 20]
debtEquityRatioTTM	0.902	-1.500	6.39	-9.59	[0 - 2.5]
grossProfitMarginTTM	0.419	1.000	6.35	6.35	[0.2 - 0.8]
operatingProfitMarginTTM	0.114	1.000	9.71	9.71	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.135	1.000	-0.360	-0.360	[0.2 - 2]
assetTurnoverTTM	0.324	0.800	-1.173	-0.938	[0.5 - 2]
Total Score				4.93

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-226.47	1.000	-10.00	0	[1 - 100]
returnOnEquityTTM	-0.00273	2.50	-0.734	-1.712	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.674	2.00	9.44	10.00	[0 - 30]
dividendYielPercentageTTM	4.52	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.04	2.00	9.32	10.00	[0 - 30]
payoutRatioTTM	-10.24	1.500	-10.00	10.00	[0 - 1]
pegRatioTTM	-23.17	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.159	1.000	8.52	0	[0.1 - 0.5]
Total Score				0.668

Viatris Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Viatris Inc.

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.